Baseline patient demographics
No of patients | 57 |
No of eyes | 71 |
Laterality, # cases (%) | |
Right | 39 (54.9) |
Left | 32 (45.1) |
Gender, # patients (%) | |
Male | 30 (52.6) |
Female | 27 (47.4) |
Age in years: median (mean±D) | 47 (45.77±11.8) |
Ethnicity, # patients (%) | |
White | 28 (49.1) |
African American | 20 (35.1) |
Asian | 0 (0.0) |
Hispanic | 7 (12.3) |
Other | 2 (3.5) |
Diabetes classification, # patients (%) | |
Type 1 | 20 (35.1) |
Type 2 | 37 (64.9) |
Insulin-dependent diabetes | 47 (82.5) |
Diabetes severity parameters | |
Preoperative A1C (%): median (mean±SD) | 8.85 (9.02±2.20) |
Duration of diabetes (years): median (mean±SD) | 20 (19.25±8.81) |
Duration of insulin use (years): median (mean±SD) | 13 (14.73±11.60) |
Medical comorbidities, # patients (%) | |
Hypertension | 46 (80.7) |
Dialysis | 2 (3.5) |
Peripheral vascular disease | 12 (21.1) |
Major adverse cardiovascular event | 13 (22.8) |
Other end organ damage | 27 (47.4) |
History of ophthalmic interventions, # patients (%) | |
Panretinal photocoagulation | 37 (64.9) |
Anti-VEGF injections | 21 (47.4) |
Baseline visual characteristics | |
Preoperative logMAR (Snellen equivalent): median (mean±SD) | 1.30 (20/400) (1.53 (20/678) ± 0.75 (20/112)) |
Baseline anatomic characteristics, # cases (%) | |
Total detachment | 11 (15.5) |
Macular detachment | 23 (31.0) |
Extramacular detachment | 24 (33.8) |
Vitreoretinal traction only | 14 (19.7) |
Follow-up in months: median (mean±SD) | 15 (16.99±9.64) |